NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
NOXXON Pharma AG
ClinicalTrials.gov Identifier:
NCT01547897
First received: February 27, 2012
Last updated: February 21, 2014
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)